{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:08:05Z","timestamp":1793142485358,"version":"4.5.0"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and clinically relevant adverse effect of chemotherapy, negatively impacting patient quality of life. The lack of effective preventive or therapeutic options regarding CIPN often requires changes in cancer therapy, potentially resulting in reduced survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine whether sensorimotor training (SMT) and whole-body vibration (WBV) training reduce symptoms and decrease the onset of CIPN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This prospective multicenter randomized clinical trial (STOP) followed up patients over 5 years at 4 centers in or near Cologne, Germany. Patients undergoing treatment with oxaliplatin or vinca alkaloids were recruited. Participants were recruited from May 2014 to November 2020. Data were last analyzed in June 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Participants in the intervention groups performed supervised SMT or WBV training sessions twice a week, each lasting approximately 15 to 30 minutes, concomitant to medical therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary end point was the incidence of CIPN. Secondary end points included subjective neuropathy symptoms, balance control, physical activity levels, quality of life, and clinical outcome. For cross-stratum evaluations, the Mantel-Haenszel test (MH) was used, and within individual strata, Fisher exact test was used for analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1605 patients were screened, and 1196 patients did not meet all inclusion criteria, with 251 further excluded or declining participation. A total of 158 patients (mean [SD] age, 49.1 [18.0-82.0] years; 93 [58.9%] male) were randomized into 1 of 3 groups: 55 (34.8%) in SMT, 53 (33.5%) in WBV, and 50 (31.6%) in treatment as usual (TAU). The incidence of CIPN in participants was significantly lower in both intervention groups compared to the control group (TAU): (SMT, 12 of 40 [30.0%; 95% CI, 17.9%-42.1%] and WBV, 14 of 34 [41.2%; 95% CI, 27.9%-54.5%] vs TAU, 24 of 34 [70.6%; 95% CI, 58.0%-83.2%]; <jats:italic>P<\/jats:italic>\u2009=\u2009.002 for intention to treat\u2013MH). Patients receiving vinca alkaloids and performing SMT benefited the most. Results were more pronounced in a per-protocol analysis (&amp;amp;gt;75% participation in the intervention) (SMT, 8 of 28 [28.6%; 95% CI, 16.6%-40.5%] and WBV, 9 of 24 [37.5%; 95% CI, 24.4%-50.5%] vs TAU, 22 of 30 [73.3%; 95% CI, 61.6%-85.6%]). Improvements in favor of SMT compared to TAU were found for balance control bipedal with eyes open; bipedal with eyes closed; monopedal, vibration sensitivity, sense of touch, lower leg strength, pain reduction, burning sensation, chemotherapy dose reductions, and mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion and Relevance<\/jats:title><jats:p>This randomized clinical trial provides initial evidence that neuromuscular training decreases the onset of CIPN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>German Clinical Trials Register: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/drks.de\/search\/en\/trial\/DRKS00006088\">DRKS00006088<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamainternmed.2024.2354","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T15:01:26Z","timestamp":1719846086000},"page":"1046","source":"Crossref","is-referenced-by-count":54,"title":["Preventive Effect of Neuromuscular Training on Chemotherapy-Induced Neuropathy"],"prefix":"10.1001","volume":"184","author":[{"given":"Fiona","family":"Streckmann","sequence":"first","affiliation":[{"name":"Department of Sport, Exercise and Health, University of Basel, Basel, Switzerland"},{"name":"Department of Oncology, University Hospital Basel, Basel, Switzerland"},{"name":"Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Elter","sequence":"additional","affiliation":[{"name":"Department 1 of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmar C.","family":"Lehmann","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Cologne, Cologne, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansj\u00f6rg","family":"Baurecht","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Nazarenus","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Oschwald","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Koliamitra","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Otten","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Draube","sequence":"additional","affiliation":[{"name":"Praxis Internistischer Onkologie und Haematologie (PIOH), Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Heinen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Saint Antonius Hospital, Eschweiler, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Steinmetz","sequence":"additional","affiliation":[{"name":"Outpatient Clinic for Hematology and Oncology, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hallek","sequence":"additional","affiliation":[{"name":"Department 1 of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Leitzmann","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Bloch","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Balke","sequence":"additional","affiliation":[{"name":"Department of Neurological and Early Rehabilitation, Saint Mary Hospital Cologne, Cologne, Germany"},{"name":"Department of Rehabilitation Sciences, Faculty of Health, University of Witten\/Herdecke, Witten, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"ioi240038r1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cancers12061370","article-title":"Management of oxaliplatin-induced peripheral sensory neuropathy.","volume":"12","author":"Cavaletti","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"ioi240038r2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22041980","article-title":"Peripheral neuropathy under oncologic therapies: a literature review on pathogenetic mechanisms.","volume":"22","author":"Laforgia","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ioi240038r3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000094376","article-title":"Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up.","volume":"56","author":"Pietrangeli","year":"2006","journal-title":"Eur Neurol"},{"issue":"6","key":"ioi240038r4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/00325481.1996.11946142","article-title":"Peripheral neuropathy: an often-overlooked cause of falls in the elderly.","volume":"99","author":"Richardson","year":"1996","journal-title":"Postgrad Med"},{"key":"ioi240038r5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2009.0078","article-title":"NCCN task force report: management of neuropathy in cancer.","volume":"7","author":"Stubblefield","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"issue":"28","key":"ioi240038r6","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"issue":"9","key":"ioi240038r7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1212\/WNL.0000000000006083","article-title":"Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations.","volume":"91","author":"Gewandter","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"ioi240038r8","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1152\/jn.00152.2002","article-title":"Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity.","volume":"88","author":"G\u00f3mez-Pinilla","year":"2002","journal-title":"J Neurophysiol"},{"issue":"22","key":"ioi240038r9","doi-asserted-by":"publisher","first-page":"8473","DOI":"10.1073\/pnas.0401443101","article-title":"Voluntary exercise increases axonal regeneration from sensory neurons.","volume":"101","author":"Molteni","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ioi240038r10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neulet.2012.11.036","article-title":"Human cutaneous sensors on the sole of the foot: altered sensitivity and recovery time after whole body vibration.","volume":"533","author":"Sonza","year":"2013","journal-title":"Neurosci Lett"},{"key":"ioi240038r11","article-title":"Exercise and neuropathy: systematic review with meta-analysis.","author":"Streckmann","year":"2021","journal-title":"Sports Med"},{"issue":"7","key":"ioi240038r12","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s00520-018-4531-4","article-title":"Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy-a randomized controlled pilot trial.","volume":"27","author":"Streckmann","year":"2019","journal-title":"Support Care Cancer"},{"issue":"2","key":"ioi240038r13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/aps.2008.193.issue-2","article-title":"Spinal and supraspinal adaptations associated with balance training and their functional relevance.","volume":"193","author":"Taube","year":"2008","journal-title":"Acta Physiol (Oxf)"},{"issue":"2","key":"ioi240038r14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1055\/s-0030-1268010","article-title":"Vibration exercise: the potential benefits.","volume":"32","author":"Cochrane","year":"2011","journal-title":"Int J Sports Med"},{"issue":"20","key":"ioi240038r15","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"ioi240038r16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1212\/WNL.0000000000004272","article-title":"Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendations.","volume":"89","author":"Gewandter","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"ioi240038r17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/annonc\/mds329","article-title":"The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.","volume":"24","author":"Cavaletti","year":"2013","journal-title":"Ann Oncol"},{"key":"ioi240038r18","first-page":"30","article-title":"Exercise in cancer recovery: An overview of the evidence.","author":"Hayes","year":"2006","journal-title":"Cancer Forum"},{"issue":"8","key":"ioi240038r19","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1249\/MSS.0b013e31821ece12","article-title":"2011 Compendium of Physical Activities: a second update of codes and MET values.","volume":"43","author":"Ainsworth","year":"2011","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"ioi240038r20","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1172\/JCI83871","article-title":"Cancer immunotherapy: harnessing the immune system to battle cancer.","volume":"125","author":"Yang","year":"2015","journal-title":"J Clin Invest"},{"key":"ioi240038r21","article-title":"Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and non\u2013small cell lung cancer.","volume":"2012","author":"Pike","year":"2012","journal-title":"Chemother Res Pract"},{"issue":"3","key":"ioi240038r22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090245","article-title":"Treadmill exercise induced functional recovery after peripheral nerve repair is associated with increased levels of neurotrophic factors.","volume":"9","author":"Park","year":"2014","journal-title":"PLoS One"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2820720\/jamainternal_streckmann_2024_oi_240038_1724793948.10943.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T15:08:58Z","timestamp":1725376138000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2820720"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2024.2354","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}